Research ArticleDrug Discovery and Translational Medicine
Pharmacology of AMG 416 (Velcalcetide), a Novel Peptide Agonist of the Calcium-Sensing Receptor, for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
Sarah Walter, Amos Baruch, Jin Dong, James E. Tomlinson, Shawn T. Alexander, Julie Janes, Tom Hunter, Qun Yin, Derek Maclean, Gregory Bell, Dirk B. Mendel, Randolph M. Johnson and Felix Karim
Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 229-240; DOI: https://doi.org/10.1124/jpet.113.204834
Sarah Walter
Amgen, Inc., South San Francisco, California (S.W., A.B., J.D., J.E.T., S.T.A., J.J., T.H., Q.Y., D.B.M., G.B., D.M., R.M.J., F.K.); and Department of Medicine, University of California, San Francisco, California (G.B.)
Amos Baruch
Amgen, Inc., South San Francisco, California (S.W., A.B., J.D., J.E.T., S.T.A., J.J., T.H., Q.Y., D.B.M., G.B., D.M., R.M.J., F.K.); and Department of Medicine, University of California, San Francisco, California (G.B.)
Jin Dong
Amgen, Inc., South San Francisco, California (S.W., A.B., J.D., J.E.T., S.T.A., J.J., T.H., Q.Y., D.B.M., G.B., D.M., R.M.J., F.K.); and Department of Medicine, University of California, San Francisco, California (G.B.)
James E. Tomlinson
Amgen, Inc., South San Francisco, California (S.W., A.B., J.D., J.E.T., S.T.A., J.J., T.H., Q.Y., D.B.M., G.B., D.M., R.M.J., F.K.); and Department of Medicine, University of California, San Francisco, California (G.B.)
Shawn T. Alexander
Amgen, Inc., South San Francisco, California (S.W., A.B., J.D., J.E.T., S.T.A., J.J., T.H., Q.Y., D.B.M., G.B., D.M., R.M.J., F.K.); and Department of Medicine, University of California, San Francisco, California (G.B.)
Julie Janes
Amgen, Inc., South San Francisco, California (S.W., A.B., J.D., J.E.T., S.T.A., J.J., T.H., Q.Y., D.B.M., G.B., D.M., R.M.J., F.K.); and Department of Medicine, University of California, San Francisco, California (G.B.)
Tom Hunter
Amgen, Inc., South San Francisco, California (S.W., A.B., J.D., J.E.T., S.T.A., J.J., T.H., Q.Y., D.B.M., G.B., D.M., R.M.J., F.K.); and Department of Medicine, University of California, San Francisco, California (G.B.)
Qun Yin
Amgen, Inc., South San Francisco, California (S.W., A.B., J.D., J.E.T., S.T.A., J.J., T.H., Q.Y., D.B.M., G.B., D.M., R.M.J., F.K.); and Department of Medicine, University of California, San Francisco, California (G.B.)
Derek Maclean
Amgen, Inc., South San Francisco, California (S.W., A.B., J.D., J.E.T., S.T.A., J.J., T.H., Q.Y., D.B.M., G.B., D.M., R.M.J., F.K.); and Department of Medicine, University of California, San Francisco, California (G.B.)
Gregory Bell
Amgen, Inc., South San Francisco, California (S.W., A.B., J.D., J.E.T., S.T.A., J.J., T.H., Q.Y., D.B.M., G.B., D.M., R.M.J., F.K.); and Department of Medicine, University of California, San Francisco, California (G.B.)
Dirk B. Mendel
Amgen, Inc., South San Francisco, California (S.W., A.B., J.D., J.E.T., S.T.A., J.J., T.H., Q.Y., D.B.M., G.B., D.M., R.M.J., F.K.); and Department of Medicine, University of California, San Francisco, California (G.B.)
Randolph M. Johnson
Amgen, Inc., South San Francisco, California (S.W., A.B., J.D., J.E.T., S.T.A., J.J., T.H., Q.Y., D.B.M., G.B., D.M., R.M.J., F.K.); and Department of Medicine, University of California, San Francisco, California (G.B.)
Felix Karim
Amgen, Inc., South San Francisco, California (S.W., A.B., J.D., J.E.T., S.T.A., J.J., T.H., Q.Y., D.B.M., G.B., D.M., R.M.J., F.K.); and Department of Medicine, University of California, San Francisco, California (G.B.)

JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleDrug Discovery and Translational Medicine
AMG 416 (Velcalcetide) Activates the Calcium Sensing Receptor
Sarah Walter, Amos Baruch, Jin Dong, James E. Tomlinson, Shawn T. Alexander, Julie Janes, Tom Hunter, Qun Yin, Derek Maclean, Gregory Bell, Dirk B. Mendel, Randolph M. Johnson and Felix Karim
Journal of Pharmacology and Experimental Therapeutics August 1, 2013, 346 (2) 229-240; DOI: https://doi.org/10.1124/jpet.113.204834
Research ArticleDrug Discovery and Translational Medicine
AMG 416 (Velcalcetide) Activates the Calcium Sensing Receptor
Sarah Walter, Amos Baruch, Jin Dong, James E. Tomlinson, Shawn T. Alexander, Julie Janes, Tom Hunter, Qun Yin, Derek Maclean, Gregory Bell, Dirk B. Mendel, Randolph M. Johnson and Felix Karim
Journal of Pharmacology and Experimental Therapeutics August 1, 2013, 346 (2) 229-240; DOI: https://doi.org/10.1124/jpet.113.204834
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement